March 2016

Make the Most of Business Travel

Allen C. Ho, MD, and Robert L. Avery, MD

Retina News

Highlights From the 2016 Cairo Retina Meeting

Medical Update

Ocular Gene Therapy Trials Advance

Results of the first phase 3 trial were announced.

Aron Shapiro

You Can Observe a Lot Just By Watching

Donald D'Amico, MD, and Yogi Berra join forces to deliver wisdom to second-year retina fellows in Chicago.

Bryan Kun Hong, MD

Troubleshooting the 7th Character

A primer on using A, D, and S characters in ICD-10-CM vitreoretinal coding.

Riva Lee Asbell

Perfluorocarbon Liquid: Handle With Care

A quick guide to avoiding retained subretinal PFCL and removing it when it occurs.

Masahito Ohji, MD

New Design Elements Boost Vitrectomy Efficiency

High-speed cutter and SPEEP vacuum mode among the innovations of the OS4 vitrectomy machine.

Armin Wolf, MD, FEBO

Inside the Uveitis Toolbox

An examination of the delivery methods available for releasing steroids into the posterior segment.

Tahreem A. Mir, MD, and Ashvini K. Reddy, MD

An Unusual Case of Retinal Metastasis

Lung cancer metastasis to the retina and vitreous masqueraded as diffuse retinal vasculitis and vitritis.

Sanket U. Shah, MD; Ann T. Moriarty, MD; and Ramana S. Moorthy, MD

Imaging the Vitreous and Vitreomacular Interface

Case presentations demonstrate the utility of 3-D SD-OCT in examining in vivo details of the vitreous structure.

Manish Nagpal, MS, DO, FRCS(Edin), and Shishir Shekhar Singh, MS

Quality-Adjusted Life Years for the Retina Specialist

Understanding QALYs can help ophthalmologists see the bigger picture of treatment impact on patients' health-related quality of life.

Nancy M. Holekamp, MD; Steven B. Duff, MS; and Yamina Rajput, MS

Retinal Findings in Abusive Head Trauma

Knowing what to look for could help to identify child abuse.

Aristomenis Thanos, MD; Yoshihiro Yonekawa, MD; Kentaro Yomogida, MD; David A. Bloom, MD; Michael T. Trese, MD; and Kimberly A. Drenser, MD, PhD

Teamwork Vital in ROP Care

A team approach to retinopathy of prematurity care helps to streamline the process.

Basil K. Williams Jr, MD

Identifying and Monitoring Diabetic Retinopathy

Recognizing the strengths and drawbacks of different imaging modalities for managing patients with diabetic eye disease.

David A. Salz, MD, and Andre J. Witkin, MD

Evaluating Changes in Diabetic Retinopathy

A case report illustrates how structural and functional assessments can be interpreted and correlated to provide a comprehensive patient evaluation.

Vinicius Castro, MD, PhD, and Thomas W. Gardner, MD, MS

Comparing Treatment Options for Proliferative Diabetic Retinopathy

Study design and results of DRCR.net Protocol S.

Carl W. Baker, MD

The Landscape of Steroid Therapy for DME

Steroids are important treatment options, available in multiple formulations that allow them to be tailored to individual patient needs.

Margaret A. Greven, MD, and Peter Karth, MD, MBA

Managing Diabetic Eye Disease With Intravitreal Anti-VEGF Injections

Key clinical trials compare the use of anti-VEGF agents alone and in conjunction with laser therapy.

Andrew M. Hendrick, MD, and Michael S. Ip, MD

Can Long-Term Response to Anti-VEGF Therapy Be Predicted After Three Injections in Patients With DME?

A post hoc analysis of the ranibizumab arms from Protocol I points to “yes.”

Pravin U. Dugel, MD

5Q With Peter Karth, MD, MBA

Peter Karth, MD, MBA, is an Assistant Clinical Professor of Ophthalmology at the Byers Eye Institute at the Stanford University School of Medicine.